Latest filing published 16 Nov 2018 for Corbus Pharmaceuticals Holdings, Inc., €8,841.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -40.7%Entry US$90.00 · Close at T+365 US$53.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Mark Tepper: trading record in brief
Mark Tepper discloses dealings in 2 companies, chiefly Cytrx Corp and Corbus Pharmaceuticals Holdings, Inc. Over a trading history stretching from 27 April 2007 to 14 November 2018, the count stands at 16 filings.
The open-market side counts 1 purchase for €4,906 alongside 10 sales for €696k. Netting one side against the other leaves €691k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 5 option exercises.
On 16 November 2018 came the latest disclosure, an option exercise for €8,841 in Corbus Pharmaceuticals Holdings, Inc. The last purchase on record was published on 26 November 2014, which is 4,366 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Mark Tepper
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$1.00100.0% of flowCommon StockSEC:0001209191-18-058931:0
- 2,000 shares@ US$3.05Common StockSEC:0001209191-14-071371:0Canonical exit: 23 Feb 2015 (T+90)
- 75,000 shares@ US$2.41Common StockSEC:0001250853-07-000074:0
- 74,400 shares@ US$4.30Common StockSEC:0001250853-07-000074:1
- 600 shares@ US$4.31Common StockSEC:0001250853-07-000074:2
- 30,000 shares@ US$2.41Common StockSEC:0001250853-07-000073:1
- 45,000 shares@ US$2.41Common StockSEC:0001250853-07-000073:0
- 20,169 shares@ US$4.15Common StockSEC:0001250853-07-000073:2
- 300 shares@ US$4.16Common StockSEC:0001250853-07-000073:3
- 9,881 shares@ US$4.17Common StockSEC:0001250853-07-000073:4
- 300 shares@ US$4.18Common StockSEC:0001250853-07-000073:5
- 3,050 shares@ US$4.19Common StockSEC:0001250853-07-000073:6
- 29,730 shares@ US$4.20Common StockSEC:0001250853-07-000073:7
- 11,570 shares@ US$4.21Common StockSEC:0001250853-07-000073:8
- 75,000 shares@ US$2.41Common StockSEC:0001250853-07-000070:0
- 75,000 shares@ US$4.11Common StockSEC:0001250853-07-000070:1
16 of 16 declarations